Published: Mon, December 04, 2017
Medicine | By Brett Sutton

Palace assures: No severe dengue case yet

Palace assures: No severe dengue case yet

The developer of the world's first vaccine for the potentially deadly virus, French pharmaceutical giant Sanofi, revealed earlier this week that it could trigger more severe symptoms in people who had not been previously infected with dengue.

According to Presidential spokesperson Harry Roque, those behind the program will be held responsible and that the Department of Health (DOH) is now closely monitoring those who have received the vaccine.

Sanofi said Wednesday that analysis based on up to six years of clinical data showed that in the longer term, more cases of severe dengue can occur following vaccination among people who have not had previous dengue infection.

Spokesman Eric Tayag said the agency was "prepared for a worst-case scenario" and that children who have received it are being "followed up for adverse effects following immunisation".

"However, we call on all citizens not to spread information that may cause undue alarm", Roque said.


Announcing the suspension of the vaccination program, Health Secretary Francisco Duque III said new recommendations would be released later this month by the Strategic Advisory Group of Experts on Immunisation, an advisory body of the World Health Organisation.

"We will leave no stone unturned in making those responsible for this shameless public health scam which puts hundreds of thousands of young lives at risk accountable", Roque said in a statement.

"Our present health officials are serious in carrying out their mandate to always guard the health and physical well-being of our people, which includes intensifying surveillance and evaluation of our dengue vaccination program", Roque said.

Dengvaxia had been administered to more than 700,000 public school children from Central Luzon, Calabarzon and National Capital Region.

Health Secretary Francisco Duque III said further recommendation will be released on December 12 or 13 by the Strategic Advisory Group of Experts on immunization, an advisory body of the World Health Organization.

Like this: